Obesity Featured Articles

  1. Why Travel Concierge Support Makes A Difference 11/2/2026

    Where every participant is irreplaceable, sustained human support through relocation, crisis, and distance can decide whether a family completes a rare disease protocol. Three family stories illustrate the stakes.

  2. Improving Transparency And Credibility Of Real-World Evidence: The HARPER Template 11/2/2026

    HARPER brings consistency to real-world evidence studies, improving transparency and reproducibility while supporting clearer evaluation of methods and findings.

  3. Brazil's Regulatory Transformation: A New Era For Clinical Development 11/2/2026

    Brazil’s clinical research transformation takes center stage as this new Q&A series opens with Interfarma CEO and former ANVISA director Renato Porto.

  4. Modern Site Operating Models For Complex Portfolios 10/31/2026

    When injectable and biologic volumes swing and disruption is barely tolerated, can a packaging plant organized by function keep pace? Splitting one site into focus factories suggests another model.

  5. Omics-Driven Immune Challenge Design: What Early Human Data Tells Us 10/31/2026

    Transcriptomic and proteomic profiling of controlled human immune challenges shows which pathways, compartments, and time windows a model engages, helping match challenge choice to a drug's mechanism.

  6. What Can Healthy Participants Tell Us In Early Immuno-oncology Development? 10/31/2026

    Healthy participants may help answer early immuno-oncology questions when targets, endpoints, and risks align. Human data shows where this approach works and where it doesn’t.

  7. The Scout Effect: Helping Keep Clinical Trials On Track 10/29/2026

    Experience the stability that comes when patients, sites, and sponsors each get the support they need to keep moving without interruption.

  8. Can Reimbursement Assumptions Create Participant Burden In Clinical Trials? 10/29/2026

    Reimbursement policies often rest on assumptions about travel, timing, and participant costs. Learn how those assumptions can create a burden on participants and what you should test before enrollment.

  9. The Real Problem In Patient Recruitment… Is Knowing How And When To Use AI 10/29/2026

    AI might find patients faster, but only people earn their trust. A site COO explains how to pair AI speed with human judgment, plus the guardrails every site should build in.

  10. An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs? 10/28/2026

    FDA’s real-time CRL releases face legal and operational hurdles. Could AI-assisted redaction make transparency faster and more consistent?